News Release

Online prescribing of GLP-1 receptor agonists

JAMA

Peer-Reviewed Publication

JAMA Network

About The Study: This secret shopper study found that online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors often did not require clinician interaction, relying primarily on patient-reported questionnaires that may not capture important clinical and social history. Several findings suggest limited oversight: multiple GLP-1 RA prescriptions from the same clinicians, prescriptions issued despite missing required photos, and prescriptions issued within 5 minutes or less.

Corresponding Author: To contact the corresponding author, Reshma Ramachandran, MD, MPP, MHS, email reshma.ramachandran@yale.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2026.9131)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2026.9131?guestAccessKey=fa92b2cf-8029-44c4-a5ea-da5b3d264967&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070626


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.